Yao R - Search Results

1

FOXM1 mediates resistance to docetaxel in gastric cancer via up-regulating Stathmin.

Li X, Yao R, Yue L, Qiu W, Qi W, Liu S, Yao Y, Liang J. Li X, et al. Among authors: yao y, yao r. J Cell Mol Med. 2014 May;18(5):811-23. doi: 10.1111/jcmm.12216. Epub 2014 Mar 14. J Cell Mol Med. 2014. PMID: 24628949 Free PMC article.

2

A novel and effective hepatocyte growth factor kringle 1 domain and p53 cocktail viral gene therapy for the treatment of hepatocellular carcinoma.

Shen Z, Wong OG, Yao RY, Liang J, Kung HF, Lin MC. Shen Z, et al. Cancer Lett. 2008 Dec 18;272(2):268-76. doi: 10.1016/j.canlet.2008.03.064. Epub 2008 Aug 21. Cancer Lett. 2008. PMID: 18722051

3

The combination of ERCC1 and XRCC1 gene polymorphisms better predicts clinical outcome to oxaliplatin-based chemotherapy in metastatic colorectal cancer.

Liang J, Jiang T, Yao RY, Liu ZM, Lv HY, Qi WW. Liang J, et al. Cancer Chemother Pharmacol. 2010 Aug;66(3):493-500. doi: 10.1007/s00280-009-1186-3. Epub 2009 Dec 4. Cancer Chemother Pharmacol. 2010. PMID: 19960344

4

Genetic polymorphism of GSTP1: prediction of clinical outcome to oxaliplatin/5-FU-based chemotherapy in advanced gastric cancer.

Li QF, Yao RY, Liu KW, Lv HY, Jiang T, Liang J. Li QF, et al. J Korean Med Sci. 2010 Jun;25(6):846-52. doi: 10.3346/jkms.2010.25.6.846. Epub 2010 May 24. J Korean Med Sci. 2010. PMID: 20514304 Free PMC article.

5

[Association between genetic polymorphisms of ERCC1, XRCC1, GSTP1 and survival of advanced gastric cancer patients treated with oxaliplatin/5-Fu-based chemotherapy].

Liang J, Li QF, Yao RY, Lü HY, Jiang J, Sun YY, Song SA, Jiang T. Liang J, et al. Zhonghua Zhong Liu Za Zhi. 2010 Jul;32(7):515-9. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 21029695 Chinese.

6

Genetic polymorphisms of GSTP1 and XRCC1: prediction of clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer (NSCLC) patients.

Zhou F, Yu Z, Jiang T, Lv H, Yao R, Liang J. Zhou F, et al. Among authors: yao r. Swiss Med Wkly. 2011 Oct 19;141:w13275. doi: 10.4414/smw.2011.13275. eCollection 2011. Swiss Med Wkly. 2011. PMID: 22009704 Free article.

7

Adenovirus-mediated TRAIL expression and downregulation of Bcl-2 expression suppresses non-small cell lung cancer growth in vitro and in vivo.

Zhang H, Sui A, Wang Z, Liu S, Yao R. Zhang H, et al. Among authors: yao r. Int J Mol Med. 2012 Aug;30(2):358-64. doi: 10.3892/ijmm.2012.998. Epub 2012 May 14. Int J Mol Med. 2012. PMID: 22614533

8

Inhibition of hepatocellular carcinoma cell growth by an anti-insulin-like growth factor-I receptor monoclonal antibody.

Yue L, Wang Y, Wang H, Gao H, Liang J, Sui A, Xiang J, Zhou F, Xu C, Zhao W, Liang W, Yao R. Yue L, et al. Among authors: yao r. Oncol Rep. 2012 Oct;28(4):1453-60. doi: 10.3892/or.2012.1960. Epub 2012 Aug 8. Oncol Rep. 2012. PMID: 22895605

9

Induction of non-small cell lung carcinoma apoptosis using soluble RGD-TRAIL by targeting the integrin receptor of tumor cells.

Yao R, Sui A, Wang Z, Liu S, Zhou Q, Liu X, Zhang H. Yao R, et al. Mol Med Rep. 2012 Dec;6(6):1355-60. doi: 10.3892/mmr.2012.1071. Epub 2012 Sep 10. Mol Med Rep. 2012. PMID: 22965279

10

Differential expression of the Na(+)/I(-) symporter protein in thyroid cancer and adjacent normal and nodular goiter tissues.

Wang S, Liang J, Lin Y, Yao R. Wang S, et al. Among authors: yao r. Oncol Lett. 2013 Jan;5(1):368-372. doi: 10.3892/ol.2012.947. Epub 2012 Oct 1. Oncol Lett. 2013. PMID: 23255951 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,077 results

Search Page

Filters